OptimizeRx (OPRX) Depreciation & Amortization (IS) (2022 - 2025)
Historic Depreciation & Amortization (IS) for OptimizeRx (OPRX) over the last 7 years, with Q3 2025 value amounting to $1.1 million.
- OptimizeRx's Depreciation & Amortization (IS) fell 136.99% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year increase of 235.74%. This contributed to the annual value of $4.3 million for FY2024, which is 8022.48% up from last year.
- According to the latest figures from Q3 2025, OptimizeRx's Depreciation & Amortization (IS) is $1.1 million, which was down 136.99% from $1.1 million recorded in Q2 2025.
- In the past 5 years, OptimizeRx's Depreciation & Amortization (IS) registered a high of $1.1 million during Q3 2024, and its lowest value of $456545.0 during Q4 2022.
- Its 4-year average for Depreciation & Amortization (IS) is $800135.3, with a median of $1.0 million in 2023.
- In the last 5 years, OptimizeRx's Depreciation & Amortization (IS) tumbled by 1956.65% in 2023 and then surged by 13447.54% in 2024.
- OptimizeRx's Depreciation & Amortization (IS) (Quarter) stood at $456545.0 in 2022, then skyrocketed by 120.57% to $1.0 million in 2023, then increased by 8.64% to $1.1 million in 2024, then dropped by 1.28% to $1.1 million in 2025.
- Its Depreciation & Amortization (IS) stands at $1.1 million for Q3 2025, versus $1.1 million for Q2 2025 and $1.1 million for Q1 2025.